Hallersten, Anna <br/><br/>
Physicians prefer greater detail in the biosimilar label (SmPC) - Results of a survey across seven European countries.  [electronic resource] 

 -  Regulatory toxicology and pharmacology : RTP  Jun 2016 
 - 275-81 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1096-0295 
<br/><br/><label>Standard No.: </label>10.1016/j.yrtph.2016.03.021  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Attitude of Health Personnel<br/>Biosimilar Pharmaceuticals--therapeutic use<br/>Drug Information Services--legislation & jurisprudence<br/>Drug Labeling--legislation & jurisprudence<br/>Drug and Narcotic Control--legislation & jurisprudence<br/>Europe<br/>Government Regulation<br/>Humans<br/>Information Dissemination--legislation & jurisprudence<br/>Physicians--psychology<br/>Surveys and Questionnaires